A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?

MLA

Perga, Simona, et al. “A20 in Multiple Sclerosis and Parkinson’s Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?” Neurotoxicity Research, vol. 32, no. 1, July 2017, pp. 1–7. EBSCOhost, https://doi.org/10.1007/s12640-017-9724-y.

APA

Perga, S., Martire, S., Montarolo, F., Navone, N., Calvo, A., Fuda, G., Marchet, A., Leotta, D., Chiò, A., & Bertolotto, A. (2017). A20 in Multiple Sclerosis and Parkinson’s Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways? Neurotoxicity Research, 32(1), 1–7. https://doi.org/10.1007/s12640-017-9724-y

Chicago

Perga, Simona, Serena Martire, Francesca Montarolo, Nicole Navone, Andrea Calvo, Giuseppe Fuda, Alberto Marchet, Daniela Leotta, Adriano Chiò, and Antonio Bertolotto. 2017. “A20 in Multiple Sclerosis and Parkinson’s Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?” Neurotoxicity Research 32 (1): 1–7. doi:10.1007/s12640-017-9724-y.